NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Considering the NWBO specifically listed the issues with their trials. it certainly is NOT cherry-picking. It is specifically relevant to the trial, was not included in any other press releases or presentations. They buried it in SEC filings that, they knew most investors wouldn't read. But it is the facts and regulators will certainly know it and it adds significant risk that they won't approve NWBO's application when they finally get around to filing it.